High risk oral contraceptive hormones do not directly enhance endothelial cell procoagulant activity in vitro.
<h4>Background</h4>Oral contraceptive (OC) use increases venous thromboembolism risk 2-5-fold. Procoagulant changes can be detected in plasma from OC users even without thrombosis, but cellular mechanisms that provoke thrombosis have not been identified. Endothelial cell (EC) dysfunction...
Saved in:
| Main Authors: | Emma G Bouck, Marios Arvanitis, William O Osburn, Yaqiu Sang, Paula Reventun, Homa K Ahmadzia, Nicholas L Smith, Charles J Lowenstein, Alisa S Wolberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0284333&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Procoagulant and Anticoagulant Factors in Childhood Hypothyroidism
by: Nevin Kilic, et al.
Published: (2012-01-01) -
Procoagulant constituents from Cordyceps militaris
by: Juanjuan Zhang, et al.
Published: (2018-12-01) -
Procoagulant effect of phosphatidylserine-exposed blood cells, endothelial cells and extracellular vesicles in patients with aortic stenosis
by: Haiyang Wang, et al.
Published: (2025-06-01) -
Non-contraceptive effects and uses of hormonal contraception
by: A. Mouton
Published: (2007-07-01) -
Expression of Procoagulant Microparticles Assessed by Thrombin Generation Test in Cirrhosis
by: Mejda Belakremi MD, et al.
Published: (2025-07-01)